Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.64B | $4.38B | $5.07B | $9.30B | $7.43B | $5.28B | $3.98B | $4.69B |
| Cost of revenue | $2.33B | $2.83B | $3.51B | $6.20B | $4.95B | $3.93B | $3.03B | $3.31B |
| Gross profit | $1.31B | $1.55B | $1.56B | $3.10B | $2.49B | $1.35B | $950.4M | $1.38B |
| Gross margin | 36.0% | 35.4% | 30.7% | 33.3% | 33.5% | 25.6% | 23.9% | 29.4% |
| R&D | $568.1M | $377.2M | $522.3M | $552.0M | $386.0M | $375.4M | $0 | $0 |
| Operating income | −$385.6M | $164.0M | −$82.4M | $895.3M | $152.4M | −$1.11B | −$956.2M | −$121.0M |
| EBITDA | −$302.2M | $249.6M | $18.8M | $1.16B | $740.3M | −$594.1M | −$661.8M | $116.0M |
| Net income | −$457.6M | $130.3M | −$114.3M | $796.0M | $45.3M | −$1.32B | −$1.12B | −$253.0M |
| Net margin | -12.6% | 3.0% | -2.3% | 8.6% | 0.6% | -25.1% | -28.2% | -5.4% |
| EPS (diluted) | -19.84 | 5.31 | -4.41 | 29.10 | 1.64 | -47.93 | -40.59 | -9.20 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds PCNEF.
No tracked institution reports a position in PCNEF as of their last filing.
No one on the platform has traded PCNEF yet.
| +2.10% |
| $49M |
| — |
| MDXHFMedX Health Corp | $0.01 | -71.43% | $4M | — |
| MEDXFMedexus Pharmaceuticals Inc. | $3.57 | +15.01% | $115M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.